Previous study reported that β2 adrenoceptors (β2AR) play a key role via rapamycin complexes 1 and 2 (mTORC1/2) in the regulation of skeletal muscle glucose oxidation in models of intrauterine growth restriction [42]. The gene discussed is ADRB2; the disease is fetal growth restriction.